InterCure (INCR)
(Delayed Data from NSDQ)
$2.66 USD
+0.02 (0.76%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $2.66 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for InterCure Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 120 | 70 | NA | NA |
Cost Of Goods | NA | 74 | 42 | NA | NA |
Gross Profit | NA | 46 | 28 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 31 | 19 | 0 | 0 |
Income After Depreciation & Amortization | 0 | 15 | 9 | 0 | 0 |
Non-Operating Income | NA | 2 | 0 | NA | NA |
Interest Expense | NA | 4 | 3 | NA | NA |
Pretax Income | NA | 13 | 6 | NA | NA |
Income Taxes | NA | 0 | 4 | NA | NA |
Minority Interest | NA | 0 | 1 | NA | NA |
Investment Gains/Losses | NA | 0 | 0 | NA | NA |
Other Income/Charges | NA | 0 | 0 | NA | NA |
Income From Cont. Operations | NA | 13 | 2 | NA | NA |
Extras & Discontinued Operations | NA | 0 | 0 | NA | NA |
Net Income (GAAP) | NA | 13 | 1 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 19 | 11 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | NA | 3 | 2 | NA | NA |
Income After Depreciation & Amortization | 0 | 15 | 9 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 45.27 | 46.92 | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | 0.30 | 0.03 | NA | NA |
Diluted Net EPS (GAAP) | NA | 0.30 | 0.03 | NA | NA |
Fiscal Year end for InterCure Ltd falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 28.08 | 31.25 |
Cost Of Goods | NA | NA | NA | NA | 21.53 |
Gross Profit | NA | NA | NA | NA | 9.72 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 8.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 1.69 |
Non-Operating Income | NA | NA | NA | NA | 0.43 |
Interest Expense | NA | NA | NA | NA | 1.62 |
Pretax Income | NA | NA | NA | NA | 0.50 |
Income Taxes | NA | NA | NA | NA | 0.48 |
Minority Interest | NA | NA | NA | NA | -0.03 |
Investment Gains/Losses | NA | NA | NA | NA | 0.00 |
Other Income/Charges | NA | NA | NA | NA | 0.00 |
Income From Cont. Operations | NA | NA | NA | 1.34 | 0.03 |
Extras & Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | NA | 1.34 | 0.06 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 46.51 | 42.80 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | 0.03 | 0.00 |
Diluted Net EPS (GAAP) | NA | NA | NA | 0.03 | 0.00 |